CN Patent

CN110678194B — 奥曲肽注射液

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2024-08-06 · 2y expired

What this patent protects

本发明涉及的无菌溶液包括：包含以浓度相当于2.0mg/ml至2.5mg/ml的奥曲肽而存在的盐形式的奥曲肽和至少一种在药学上可接受的载体中的防腐剂，其中所述无菌溶液存在于注射装置。

USPTO Abstract

本发明涉及的无菌溶液包括：包含以浓度相当于2.0mg/ml至2.5mg/ml的奥曲肽而存在的盐形式的奥曲肽和至少一种在药学上可接受的载体中的防腐剂，其中所述无菌溶液存在于注射装置。

Drugs covered by this patent

octreotide-acetate (OCTREOTIDE ACETATE)

Patent Metadata

Patent number: CN110678194B
Jurisdiction: CN
Classification: —
Expires: 2024-08-06
Drug substance claim: No
Drug product claim: No
Assignee: Sun Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.